Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on April 30, 2025

OpenAna launches First Agentic Autonomous Engineer Transforming DevOps, SRE, and Cloud Operations
OpenAna introduces the first Autonomous Engineer for end-to-end DevOps, SRE, and cloud reliability beyond AI assistants and manual toil. NEW YORK, NY, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- As enterprises demand greater reliability, faster …

Aveta Biomics Announces Abstract Acceptance for Presentation at the 2025 ASCO Annual Meeting
Aveta Biomics to present the results from Phase 2A trial of APG-157 as neoadjuvant monotherapy for head and neck cancer at ASCO 2025. BEDFORD, MA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Aveta Biomics, a clinical-stage biotechnology company …

Xeomics Joins JumpStart to Accelerate AI in Healthcare and Precision Medicine
Collaboration underscores Xeomics's ongoing commitment to the adoption of precision medicine solutions in the US BOSTON, MA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Xeomics, a precision medicine startup today announced a strategic …

Healthcare's Digital Future: CurbCutOS Champions Accessibility Ahead of The EAA Deadline
Empowering Healthcare, One Click at a Time BOISE, ID, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The European Accessibility Act (EAA) deadline looms large on June 28, 2025, urging healthcare organizations to make accessibility a priority. …

Captive Resources Launches 'Captivating Health Insights' Podcast to Equip Employers with Innovative Healthcare Solutions
A new podcast from Captive Resources shares expert insights and practical strategies to help employers control healthcare costs and improve workforce well-being ITASCA, IL, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Captive Resources’ Health …

GenBio's Chief Science Officer Professor Lindsay Brown Investigates the Microbiome-Gut-Brain Axis
"All disease begins in the gut." Hippocrates ALISO VIEJO, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- GenBio’s Chief Scientific Officer is internationally recognized for investigating the health impact of chronic diseases of Australian …

Findability Sciences Deepens Global AI Footprint with Strategic Multi-Million Dollar Expansion in Mumbai, India
New Mumbai Hub and Innovation …

Revival Research Institute Aligns Strategy and Support at Upcoming All-Hands Meeting, May 2025
SOUTHFIELD, MI, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Revival Research Institute is proud to announce its upcoming 𝐀𝐥𝐥-𝐇𝐚𝐧𝐝𝐬 𝐌𝐞𝐞𝐭𝐢𝐧𝐠, set to take place on 𝐌𝐚𝐲 𝟐, 𝟐𝟎𝟐𝟓 Themed “Digitally Driven, Process Powered: The Future of Clinical …

Jane Partners with Whereby to Deliver Secure and Reliable Virtual Healthcare Appointments
Whereby, a leading video conferencing provider, is proud to announce its partnership with Jane.app VANCOUVER, CANADA, April 30, 2025 /EINPresswire.com/ -- Whereby, a leading video conferencing provider, is proud to announce its partnership with Jane.app …

Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
NBI-1117568 is an oral, muscarinic M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with Neurocrine For more information, please read Neurocrine’s announcement (link) Tokyo, Japan …

Therasage Announces TheraVibe™: A New Advancement in Wearable Wellness Technology
herasage unveils TheraVibe™, a new line of wearable frequency-infused patches designed to support natural energy, recovery, and vitality. CALIFORNIA, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Therasage, a leading innovator in natural …

Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki will lead Nxera’s Investor Relations (IR) team in Japan …

Hidden Strength Releases New Survey on the State of Mental Health for Teenagers
LONDON, UNITED KINGDOM, April 30, 2025 /EINPresswire.com/ -- Hidden Strength, a digital platform and app designed to give free therapy and support the mental wellness of teenagers and young adults, announced the results of its comprehensive survey …

Dengue Fever Treatment Market Explosive Growth: A Deep Dive into Trends, Innovations, and Country-Wise Insights | FMI
Dengue Fever Treatment Market outlook from 2025 to 2035, highlighting growth trends, key players, and innovations driving global healthcare advancements. NEWARK, DE, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The dengue fever treatment market …

Diamond-Blackfan Anemia Syndrome Therapeutics Market to Reach USD 7,860 Million by 2035 grow at a CAGR of 4.2% | FMI
Diamond-Blackfan Anemia Syndrome therapeutics market outlook 2035 focuses on treatment advancements, market trends, and growth projections in the sector. NEWARK, DE, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The global diamond-blackfan anemia …

Enamine and Pohang Accelerator Laboratory Partner to Speed Up Fragment-Based Discovery Projects
KYIV, UKRAINE, April 30, 2025 /EINPresswire.com/ -- Enamine, the leading provider of chemical compounds and drug discovery services, and Pohang Accelerator Laboratory (PAL), a science and technology institution in South Korea, have signed a Memorandum of …

Best Probiotic for Women Weight Loss and Vaginal Health - Top Women's Probiotic Supplement for Constipation and Gut Health - YourBiology
Glasgow, April 30, 2025 (GLOBE NEWSWIRE) -- Are you searching for the best probiotics for women's weight loss and vaginal health? Did you know your gut and vaginal health are closely connected? This "gut-vagina axis" plays a pivotal role in your overall …

Best Testosterone Booster Supplement for Males Over 40: Why TestoPrime Leads for Muscle, Energy & Libido
New York City, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Testosterone Support Matters After 40 As men age, maintaining strength, stamina, and masculinity becomes increasingly difficult — and one of the biggest reasons is a steady decline in …

OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
Urcosimod phase 2 trial treating Neuropathic Corneal Pain (“NCP”) patients was initiated in October 2024 and designed as a double-masked, randomized, 12-week placebo-controlled trial. OKYO Pharma plans to analyze the efficacy data from the 17 patients who …

Best Testosterone Booster Supplements For Men: New Report Reveals Which Products Actually Work.
New York, April 30, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted resource for product research and rankings, has officially announced its list of the top 5 best testosterone boosters for men, showcasing five high-performing supplements identified through …